Genomics · Genetic Reports · Precision Wellness
Female Sexual Health
Personalized Genetic Report
Sexual HealthSexually Transmitted InfectionsSex Hormones
Accession #: MRW-26-1C38C8
Report type: Full Report
Report status: FINAL
Specimen and client information
Specimen type
Buccal (cheek) swab
Date reported
29 July 2026
Panel
Female Sexual Health
What this report covers
Sexual Health · Sexually Transmitted Infections · Sex Hormones
About this report
This report reads your DNA and sorts every result into one of five plain-language groups, so you can see at a glance what deserves attention and what does not. Nothing here is a diagnosis. A flagged result means your genetics place you above or below the average person for that trait — a reason to ask a question, not a reason to worry.
What each result group means
Worth a conversation with your doctor
These came back with a higher genetic predisposition than most people. That is not a diagnosis — it means these are the ones worth raising at your next appointment.
Running above the typical range
Your genetics point to these sitting higher than average. Often useful to know, sometimes worth monitoring.
Running below the typical range
Your genetics point to these sitting lower than average. Same idea — context, not alarm.
Working in your favour
Good news. Your genetics look protective or better than average here.
In line with most people
Nothing unusual. These were tested and came back typical — worth having on record.
Your results at a glance
How to read this. A result being flagged does not mean you have a condition — it means your genetics put you above or below the average person for that trait. Of the 17 results here, 4 came back worth discussing with a clinician and 1 came back in your favour. Bring this document to your appointment.
Worth a conversation with your doctor (4)These came back with a higher genetic predisposition than most people. That is not a diagnosis — it means these are the ones worth raising at your next appointment.
From your Female Sexual Health report
AMenopause Symptoms
More likely
Higher predisposition than 99% of people
APainful Periods
More likely
Higher predisposition than 98% of people
IL36B rs11123155 TT · NGF rs6657049 AG · IL1A rs80111889 GG · ADGRL4 rs116496586 CC · PLA2G4A rs114519942 TT · ADGRL4 rs114808492 CC · MGMT rs141275838 AA
AGenital Herpes
More likely
Higher predisposition than 98% of people
HASPIN rs7503464 AG · ANKRD30A rs148685730 TC · SH2D4B rs539848481 GC · TAMM41 rs144232229 GG · ADAM32 rs117705146 GG · ATP1B3 rs538162817 TT · CDH23 rs190960403 CC · POLR3A rs144589616 GG
ASexual Dysfunction
More likely
Higher predisposition than 90% of people
CHSY3 rs13436218 TT · MDGA2 rs1160351 CC · ABCC4 rs117651201 AA · EBF2 rs113716552 CC · S1PR1 rs76296920 AA · NNMT rs145841294 GG · FNDC3A rs78447716 AA
Running above the typical range (2)Your genetics point to these sitting higher than average. Often useful to know, sometimes worth monitoring.
From your Female Sexual Health report
HTestosterone (F)
Higher levels
Above the typical range
CYP3A7 rs45446698 TT · FKBP4 rs56196860 CC · TYK2 rs8111359 CC · NUDT2 rs61237993 AA · AKR1C3 rs36032941 AC · ABCA8 rs34931250 CT · SLC51A rs5855544 IT · MLXIPL rs13229619 GA
HEstradiol
Higher levels
Above the typical range
ESR1 rs2234693 CT · ESR1 rs2077647 CT · UIMC1 rs2454949 AA · DTNB rs199630126 AA · RHNO1 rs28990703 AG · CYP19A1 rs727479 AA · HELB rs75770066 AA · TNP1 rs13387042 GG
Running below the typical range (0)Your genetics point to these sitting lower than average. Same idea — context, not alarm.
Working in your favour (1)Good news. Your genetics look protective or better than average here.
From your Female Sexual Health report
FHeavy Periods
Less likely
Lower predisposition than 83% of people
ARL14EP rs11031006 GG · UIMC1 rs2456181 GG · DMRT1 rs10976689 AA · TERT rs72709458 CT · ITGA11 rs148079454 AA · AADACL2 rs577706273 GG · TP53 rs78378222 TT · POGLUT3 rs149934734 CC
In line with most people (10)Nothing unusual. These were tested and came back typical — worth having on record.
From your Female Sexual Health report
·Painful Intercourse
Typical likelihood
In line with the general population · 74th percentile
·Vaginal Atrophy
Typical likelihood
In line with the general population · 67th percentile
·Pelvic Inflammatory Disease
Typical likelihood
In line with the general population · 66th percentile
·Chlamydia
Typical likelihood
In line with the general population · 62th percentile
NPSR1 rs720756 TT · MT1X rs79741827 TT · MANBA rs6821248 GG · PIGN rs61755362 GG · SIGLEC1 rs150358287 CC · STARD3 rs11556624 GG · OR13F1 rs79177442 GG · SLC1A7 rs116623976 GG
·HPV Infection
Typical likelihood
In line with the general population · 46th percentile
DOK5 rs1293153 GG · RHOBTB1 rs145804860 CT · ABHD2 rs405103 CC · GPR26 rs78231715 CC · MPZL2 rs145674624 GG · TCERG1L rs186242350 CC · FDX1 rs74572764 TT · KAT6B rs192376670 CC
·Irregular Periods
Typical likelihood
In line with the general population · 36th percentile
ARL14EP rs11031005 TT · ARL14EP rs74485684 TT · BHLHE41 rs10842700 CG · BORCS7 rs78602818 GG · TPH2 rs374833420 AA · MYOM2 rs188291369 CC
·Pelvic Organ Prolapse
Typical likelihood
In line with the general population
·HIV/AIDS
Typical likelihood
In line with the general population
NTNG1 rs4118325 GG · PABPC1 rs3108919 TT · NFIB rs1556032 TT
·Bioavailable Testosterone (F)
Typical levels
In line with the general population
TNFSF12 rs727428 TT · HGFAC rs114303452 AA · CCND2 rs76895963 TT · MFSD9 rs113247979 TT · ADH1A rs11733695 GG · GNGT2 rs11653686 CC · NR2F6 rs202200760 GG · FKBP4 rs56196860 CC
·Progesterone
Typical levels
In line with the general population
HSD17B12 rs142754737 CC · SESN3 rs139203625 CC · CD34 rs138621610 GG · ARNTL rs77032081 CC · RBFOX1 rs144711998 CC · LYSMD3 rs139441768 TT · ARRDC3 rs140935700 GG · ZKSCAN5 rs34670419 GG
Methodology
Genotyping was performed on DNA extracted from a buccal (cheek) swab using a genome-wide array. Results are derived from peer-reviewed genome-wide association data and, where applicable, published clinical guidelines. Each report was scored independently against its own reference set. Percentile figures describe where your result sits relative to a reference population.
Limitations
This is a laboratory-developed test. It has not been cleared or approved by the U.S. Food and Drug Administration. Genotyping does not detect all variants in the genes assessed; the absence of a flagged result does not exclude risk. Predisposition is probabilistic and is modified by environment, lifestyle, ancestry and family history. Results must be interpreted by a qualified healthcare professional and must not be used alone to diagnose, treat, or alter any medication regimen. Marrow does not recommend, prescribe, or dose any supplement or medication.
Performing laboratory & attestation
| Performing laboratory | Gene by Gene, Ltd. |
| Laboratory address | 1445 North Loop West, Suite 760, Houston, TX 77008 |
| CLIA certification | CLIA #45D1102202 |
| CAP accreditation | CAP #7212851 · accredited through 7 October 2027 |
| Laboratory Director | Feng Zhou, PhD, MB(ASCP) |
| Specimen type | Buccal (cheek) swab — genomic DNA |
| Accession | MRW-26-1C38C8 |
| Date reported | 29 July 2026 |
This specimen was tested at Gene by Gene, Ltd., 1445 North Loop West, Suite 760, Houston, TX 77008, under CLIA #45D1102202 and CAP #7212851. Laboratory Director: Feng Zhou, PhD, MB(ASCP). Marrow Health is not a clinical laboratory and does not perform testing; Marrow prepares and delivers this report from data produced by the performing laboratory named above. Report generated 29 July 2026 · Accession MRW-26-1C38C8 · © 2026 Marrow Health.